SFCM
CGEM icon

Seven Fleet Capital Management’s Cullinan Oncology CGEM Stock Holding History

Seven Fleet Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2K Sell
1,844
-1,156
-39% -$14.9K 0.01% 115
2025
Q4 		$31.1K Buy
+3,000
New +$27.1K 0.02% 82

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Seven Fleet Capital Management's CGEM Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its Cullinan Oncology (CGEM) stake by 39% in Q1 2026, selling an estimated $14.9K and leaving 1,844 shares worth $26.2K. The position accounts for 0.01% of the portfolio, ranked #115.

Seven Fleet Capital Management first reported a position in CGEM in Q4 2025 and has held it in 2 quarters since. The position peaked at $31.1K in Q4 2025. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Seven Fleet Capital Management held 1,844 shares of Cullinan Oncology worth $26.2K as of Q1 2026.
  • Seven Fleet Capital Management sold 1,156 Cullinan Oncology shares in Q1 2026, an estimated $14.9K.
  • Cullinan Oncology made up 0.01% of Seven Fleet Capital Management's portfolio in Q1 2026, its #115 holding.
  • Seven Fleet Capital Management first reported a position in Cullinan Oncology in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Cullinan Oncology position peaked at $31.1K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.